News Overview

SJVN : The Exchange has sought clarification from SJVN Limited with respect to recent news item captioned SJVN signs pact with BHEL, REMC to develop renewable projects for Indian Railways. The response from the Company is awaited.

Promoter/Promoter Group of Responsive Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Ruchi Infrastructure Limited has informed the Exchange about Notice of Postal Ballot

Cyient Limited has informed the Exchange about press release dated 12-Apr-2022 titled Cyient Named as a Major Contender in the Everest Group PEAK Matrix?? for Digital Product Engineering Service Provider 2022

Tata Motors Limited DVR has informed the Exchange about press release dated 12-Apr-2022 titled Tata Motors Group Global Wholesales in Q4 of FY22

Pursuant to Regulation 30 and 34(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, (the SEBI LODR), we enclose herewith the Annual Report of Vesuvius India Limited (the Company) for the Financial Year ended December 31, 2021, along with the Notice of the Thirty First (31st) Annual General Meeting (AGM) of the Company scheduled to be held on Friday, May 6, 2022, at 1:30 P.M. (IST) through Video Conferencing/Other Audio Visual Means.

SALONA : Significant movement in price has been observed in Salona Cotspin Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Salona Cotspin Limited has submitted their response.

Coal India Limited has informed the Exchange about press release dated 12-Apr-2022 titled Coal India???s Rs.14.8K Cr Capex boost in FY???22

Promoter/Promoter Group of RattanIndia Enterprises Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

MEDICAMEQ : Significant movement in price has been observed in Medicamen Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Medicamen Biotech Limited has submitted their response.